FC131 Tfa

FC131 Tfa, also known as FC131 trifluoroacetate, is a synthetic cyclic peptide derivative renowned for its potent chemokine receptor antagonism, particularly targeting the CXCR4 receptor. This compound has garnered significant attention in the scientific community due to its unique structure and high affinity for its receptor, enabling researchers to dissect complex cellular signaling pathways. The molecular architecture of FC131 Tfa allows it to effectively disrupt ligand-receptor interactions, making it a valuable tool in the study of cell migration, immune response modulation, and various physiological processes. Its solubility and stability in aqueous solutions further enhance its utility in both in vitro and in vivo experimental settings, supporting a broad range of research applications.

Cancer Metastasis Research: FC131 Tfa is extensively employed in oncology research to investigate the mechanisms underlying tumor cell migration and metastasis. By antagonizing the CXCR4 receptor, it disrupts the SDF-1/CXCR4 signaling axis, which is known to facilitate the homing and invasion of malignant cells into distant tissues. Researchers utilize this peptide to delineate the role of chemokine signaling in various cancer types, enabling the identification of novel therapeutic targets aimed at inhibiting metastatic progression. The compound's ability to selectively block CXCR4-mediated pathways provides valuable insights into tumor microenvironment interactions and metastatic niche formation.

Stem Cell Mobilization Studies: In regenerative medicine and hematopoietic research, FC131 Tfa serves as a critical reagent for studying the mobilization and trafficking of stem cells. By inhibiting the CXCR4 receptor, it can induce the release of hematopoietic stem and progenitor cells from the bone marrow into peripheral circulation. This property is leveraged to explore the dynamics of stem cell movement, niche retention, and engraftment potential, thereby advancing our understanding of stem cell biology and supporting the development of strategies for stem cell transplantation and tissue repair.

Immunology and Inflammation Models: The application of FC131 Tfa extends into immunological research, where it is used to dissect the roles of chemokine receptors in immune cell trafficking and inflammatory responses. By blocking CXCR4 signaling, the peptide allows scientists to study the recruitment of leukocytes to sites of inflammation, the regulation of immune cell subsets, and the mechanisms that govern immune surveillance. Its use in various experimental models aids in unraveling the complexities of immune modulation and contributes to the identification of potential intervention points for controlling pathological inflammation.

HIV Entry and Viral Infection Research: FC131 Tfa has proven instrumental in virology studies, particularly those focused on understanding the entry mechanisms of viruses that exploit chemokine receptors. CXCR4 is a known co-receptor for certain strains of HIV, and by antagonizing this receptor, FC131 Tfa enables the investigation of viral binding, fusion, and entry processes. Researchers employ it to evaluate the impact of chemokine receptor blockade on viral infectivity and to screen for compounds that may inhibit viral transmission, thereby informing antiviral drug discovery efforts.

Neuroscience and Neural Migration: In the field of neuroscience, FC131 Tfa is utilized to explore the role of chemokine signaling in neural development and cell migration within the central nervous system. The peptide's antagonistic effects on CXCR4 provide a means to study neuronal positioning, axonal guidance, and the migration of neural progenitor cells during development and after injury. These investigations help elucidate the molecular cues that shape neural circuit formation and repair, offering potential avenues for understanding neurodevelopmental disorders and brain regeneration.

Pharmacological Screening and Drug Discovery: FC131 Tfa is frequently incorporated into high-throughput screening platforms to evaluate the efficacy of novel chemokine receptor modulators. Its well-characterized antagonistic activity serves as a benchmark for comparing the potency and selectivity of new compounds targeting the CXCR4 pathway. By providing a reliable reference in assay development, it accelerates the identification and optimization of candidate molecules for further preclinical research. The versatility and specificity of FC131 Tfa underscore its value as a research tool across diverse scientific disciplines, supporting advancements in basic, translational, and applied biomedical research.

1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

2. Emu oil in combination with other active ingredients for treating skin imperfections

3. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

4. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

5. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis